Skip to content
2000
Volume 2, Issue 1
  • ISSN: 1574-8936
  • E-ISSN: 2212-392X

Abstract

Novel biomarker identification and drug target validation are highly complex and resource-intensive processes, requiring an integral use of various tools, approaches and information. The recently developed proteomic technology features high-throughput parallel analysis of thousands of proteins in individual patients and amount populations and thus opens up the possibility of providing more details at a global level on the molecular mechanisms. With regularly updated public databases, bioinformatics can contribute to these processes by providing functional information of target candidates and correlating this information to the biological pathways. In this review, we outline recent advances of bioinformatic application in proteomic research on biomarker discovery and drug target validation. Specifically, we highlight how bioinformatics can facilitate the proteomic studies of biomarker identification and drug target validation.

Loading

Article metrics loading...

/content/journals/cbio/10.2174/157489307779314294
2007-01-01
2025-05-21
Loading full text...

Full text loading...

/content/journals/cbio/10.2174/157489307779314294
Loading

  • Article Type:
    Research Article
Keyword(s): Bioinformatics; biomarker discovery; drug design; drug development; proteomics
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test